A generic painkiller, ketorolac tromethamine, which is widely used in hospitals, is in short supply. The company that manufactures the painkiller, Hospira, recalled more than 60 lots of the drug due to contamination by crystal particles, which could cause problems if injected into patients.
Hospira has struggled in recent years to comply with requirements about the quality of its drugs. It notified customers in January that it was recalling some of its vials of ketorolac that were manufactured between February 2013 and December 2014. The recall occurred after a customer reported seeing calcium crystals floating in one of the vials. If the calcium particulates were injected, they could cause inflammation, allergic reactions, or other problems.
Hospira supplies about 95 percent of the ketorolac that is used in the U.S. Another company which manufactures the other five percent has increased its production in an effort to meet the demand. Keterolac is an injected nonsteroidal anti-inflammatory drug, and is given to patients during and after certain procedures. It can lessen the need for pain-relieving opioids.
Hospira’s manufacturing problems have contributed to recalls and shortages in recent years. Several shareholder lawsuits have been filed against the company, alleging officers and directors have breached their duties by failing to correct known problems, and by misleading investors.
Fortunately, the vast majority of prescription and over-the-counter drugs manufactured in this country have been safely designed and manufactured. When a drug manufacturer fails to meet its duties to its customers, however, patients who rely on those drugs can be seriously injured or killed. Those who are harmed by a drug have legal rights against the manufacturer, including the right to sue the manufacturer for damages.
If you have been harmed by a dangerous drug, call the defective prescription drug attorneys at Kennedy Hodges at 888-894-0119. You can also visit our Facebook page to learn more about us. Call to learn more.